Clinical Trial Update: Essential Pro PMCF Study ( rEPIC04E )

View source ↗

Summary

The Essential Pro PMCF Study (rEPIC04E), sponsored by Fundación EPIC, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Snippet

Sponsor: Fundación EPIC | Conditions: Coronary Artery Disease (CAD), Ischemic Heart Disease | Status: COMPLETED